FDA Approves New 10 mg Dosing for XARELTO® (rivaroxaban) …
https://www.jnj.com/media-center/press-releases/fda-approves-new-10-mg-dosing-for-xarelto-rivaroxaban-to-reduce-the-continued-risk-of-venous-thromboembolism-vte
WEBOct 30, 2017 · TITUSVILLE, NJ, OCTOBER 30, 2017 – Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) approved the 10 mg once-daily dose of XARELTO ® (rivaroxaban) for reducing the continued risk for recurrent venous thromboembolism (VTE) after completing at least six months of initial anticoagulation …
DA: 61 PA: 4 MOZ Rank: 43 Up or Down: Up